Antibody Discovery Platform: An Opportunity Platform Providers

The rising demand for novel antibody therapy and personalized medicines to provide targeted treatment options has encouraged pharmaceutical companies to shift their focus from small molecules to discovery and development of biologics, particularly antibody-based therapeutics. The antibody discovery platform report provides an extensive study on the current market landscape and future outlook of the antibody discovery service and platform providers. Some of the most interesting insights from our study are presented below.


The Landscape Of Antibody Discovery Platform and Service Providers Is Steadily Evolving
Over 60 companies are actively involved in providing antibody discovery platform and services to pharmaceutical industry and academic institutes.


Companies Are Offering A Range Of Conventional And Novel Discovery Methods
The companies are rapidly expanding their offerings in order to maintain a competitive edge in the growing antibody discovery platform and services market

Currently, majority of antibody drug discovery service providers offers antibody discovery method to library based followed by hybridoma.

Several Platforms Are Currently Available For Licensing
In addition to service providers, a number of players providing access / licenses to their discovery platform have entered this domain

Currently, various players are offering antibody discovery platform using various methods such as triple transgenic mouse, phage display and human B-cell libraries

The Competitive Environment Has Resulted In Significant Innovation
The platform providers have continuously fostered more innovation; these platforms are designed to develop unique and differentiated.


Growing Number Of Partnerships Validate The Interest In This Industry
In addition, outsourcing and licensing opportunities have led to the establishment of several strategic partnerships and collaborations

Various industry and non-industry players have inked partnerships majorly focusing on research collaboration for antibody discovery services and platforms

We Expect Healthy Growth in the Long Term
Driven by the growing demand for novel therapeutic antibodies, the antibody discovery market is likely to witness continuous growth in the coming decade.


Fully Human Antibodies Will Continue To Gain Most Traction
Transgenic animal-based methods are likely to gain more traction; the industry will continue to focus on fully human antibodies

The market of antibody discovery services is fragmented across various segments wherein transgenic animals antibody discovery method is likely to grow at relatively higher CAGR by 2027

You can also download the SAMPLE REPORT on antibody discovery by Roots Analysis.

RootsAnalysis – Research Insights